Differential effect of β-adrenergic stimulation on the frequency- dependent electrophysiologic actions of the new Class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B

Journal of Cardiovascular Electrophysiology

Volumn 8, Issue 12, 1997, Pages 1420-1430

  Schreieck, Jürgen ^b,c   Wang, Yanggan ^b   Gjini, Viktor ^b   Korth, Michael ^a   Zrenner, Bernhard ^b   Schömig, Albert ^b   Schmitt, Claus ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Action potentials; Afterdepolarizations; Ambasilide; Beta adrenergic activation; Chromanol 293B; Class III antiarrhythmic agents; Dofetilide; Isoproterenol

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; AMBASILIDE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; CHROMANOL 293B; DOFETILIDE; ISOPRENALINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; BETA ADRENERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART PAPILLARY MUSCLE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031468470     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1997.tb01039.x     Document Type: Article

References (60)

1. Yusuf S, Peto R, Lewis J, et al: Beta-blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
2. Freedman RA, Swerdlow CD, Echt DS, et al: Facilitation of ventricular tachyarrhythmia induction by isoproterenol. Am J Cardiol 1984;54:765-770.
3. Reddy CP, Gettes LS: Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol 1979;44:705-713.
4. Jazayeri MR, VanWyhe G, Avitall B, et al: Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1989;14:705-711.
5. Morady F, Kou WH, Radish AH, et al: Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia. Circulation 1989;79:783-790.
6. Kr blockade: Implications for antifibrillatory efficacy of potassium channel blocking agents. J Am Coll Cardiol 1995;25: 1609-1624.
7. Sanguinetti MC, Jurkiewicz NK, Scott A, et al: Isoproterenol antagonizes prolongation of refractory period by class III antiarrhythmic agents E-4031 in guinea pig myocytes: Mechanisms of action. Circ Res 1991;68: 77-84.
8. Sager PT, Follmer C, Uppal P, et al: The effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Circulation 1994;90:1811-1819.
9. Groh WJ, Gibson KJ, McAnulty JH, et al: Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol. Circulation 1995;91:262-264.
10. Kato R, Ikeda N, Yabek SM, et al: Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol 1986;7:116-125.
11. Kadish AH, Chen R-F, Schmaltz S. et al: Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy. J Am Coll Cardiol 1990;16: 1240-1245.
12. Du X-J, Esler MD, Dart AM: Sympatholytic action of intravenous amiodarone in the rat heart. Circulation 1995;91:462-470.
13. Sager PT, Behboodikhah M: Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation. J Cardiovasc Electrophysiol 1996;7:102-112.
14. Shenasa H, Shenasa M: Reversibility of antiarrhythmic effects of sotalol by isoproterenol in patients with ventricular tachycardia. In Vereecke PP, Van Bogaert PP, Verdonck F, eds: Potassium Channels in Normal and Pathological Conditions. Leuven University Press, Leuven, 1995, pp. 400-406.
15. Newman D, Dorian P, Feder-Elituv R: Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans. Can J Physiol Pharmacol 1993;71:755-760.
16. Waldo AL, Camm AJ, deRuyter H, et al: Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial). Am J Cardiol 1995;75: 1023-1027.
17. Sager PT, Behboodikhah M, Ahmed R, et al: Frequency-dependent effects of beta-adrenergic stimulation on ventricular repolarization, refractoriness, and conduction in humans. (Abstract) J Am Coll Cardiol 1994;23:371A.
18. + current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:194-214.
19. sK channels by chromanol 293B. Pflügers Arch 1996;432:1094-1096.
20. sK channels in epithelia. FEBS Lett 1996;396:271-275.
21. Zhang ZH, Follmer CH, Sarma JSM, et al: Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: Block of delayed outward potassium current. J Pharmacol Exp Ther 1992;263:40-48.
22. + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 1992;262:809-817.
23. + current in ventricular myocytes of the guinea pig type. Circ Res 1995;77:140-152.
24. Veldkamp MW, van Ginneken ACG, Opthof T, et al: Delayed rectifier channels in human ventricular myocytes. Circulation 1995;92:3497-3504.
25. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:379-385.
26. + currents in human ventricular myocytes. Circ Res 1996;78:689-696.
27. Wang Z, Fermini B, Nattel S: Rapid and slow components of the delayed rectifier current in human atrial myocytes. Circ Res 1994;28:1540-1546.
28. Sager PT: Frequency-dependent electrophysiologic effect of dofetilide in humans. (Abstract) Circulation. 1995;92(Suppl):I-774.
29. Montero M, Schmitt C: Recording of transmembrane action potentials in chronic ischemic heart disease and dilated cardiomyopathy and the effects of the new class III antiarrhythmic agents d-sotalol and dofetilide. J Cardiovasc Pharmacol 1996;27:571-577.
30. Ks) in human and guinea pig ventricle (Abstract). J Am Coll Cardiol 1997;29(Suppl A):512A.
31. Schreieck J, Korth M, Weyerbrock S, et al: Rate-independent prolongation of transmembrane action potential by ambasilide in failing human myocardium. (Ab,tract) J Am Coll Cardiol 1996;27(Suppl A):374A.
32. Schmitt C, Karch M, Schreieck J, et al: Effect of the new class III antiarrhythmic agent ambasilide on monophasic and transmembrane action potential in human ventricular myocardium. (Abstract) PACE 1996;19:692.
33. Honerjäger P: The contribution of Na channel block to the negative inotropic effect of antiarrhythmic drugs. Basic Res Cardiol 1986;81:33-37.
34. Hille B: Ionic Channels of Excitable Membranes. Sinauer Assoc., Inc., Sunderland, MA, 1992.
35. Sakakibara Y, Furukawa T, Singer D, et al: Sodium current in isolated human ventricular myocytes. Am J Physiol 1993;265:H1301-H1309.
36. Coraboeuf E, Deroubaix E, Coulombe A: Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. Am J Physiol 1995;236:H561-H567.
37. Honerjäger P, Reiter M: Sarcolemmal sodium permeability and contractile force of guinea pig papillary muscle: Effects of germitrine. Circ Res 1977;40:90-98.
38. Cranefield PF, Aronson RS: Cardiac Arrhythmias: The Role of Triggered Activity and Other Mechanisms. Futura Publishing Co., Inc., Mount Kisco, NY. 1988.
39. Yazawa K, Kameyama M: Mechanism of receptor-mediated modulation of the delayed outward potassium current in guinea-pig ventricular myocytes. J Physiol 1990;421:135-150.
40. Korth M, Schmied R: Differential effects of (-)-norepinephrine and of (±)-isoproterenol on cardiac contraction, an uptake phenomenon. J Pharmacol Exp Ther 1988;247:1164-1171.
41. Koidel B, Flaschberger P, Schaffer P, et al: Effects of the class III antiarrhythmic drug ambasilide on out-ward currents in human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol 1996;353:226-232.
42. Matsuura H, Ehara T, Imoto Y: An analysis of the delayed outward current in single ventricular cells of the guinea-pig. Pflügers Arch 1987;410:596-603.
43. + channels and muscarinic receptor stimulation. J Pharmacol Exp Ther 1995;273:1095-1104.
44. Carmeliet E, Mubagwa K: Changes by acetylcholine of membrane currents in rabbit cardiac Purkinje fibres. J Physiol (Lond) 1986;371:201-217.
45. Pappano AJ, Mubagwa K: Actions of muscarinic agents and adenosine on the heart. In Fozzard HA, ed: The Heart and the Cardiovascular System. Raven Press, New York, 1992, pp. 1765-1776.
46. Takanaka C, Sarma JSM, Singh BN: Electrophysiologic effects of ambasilide (LU 47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle. J Cardiovasc Pharmacol 1992;19:290-298.
47. Levesque PC, Clark CD, Zakarov SI, et al: Anion and cation modulation of the guinea-pig ventricular action potential during beta-adrenoceptor stimulation. Pflügers Arch 1993;424:54-62.
48. Wang J, Feng J, Nattel S: Class III antiarrhythmic drug action in experimental atrial fibrillation: Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide. Circulation 1994;90:2032-2040.
49. Ks in guinea pig ventricular myocytes. (Abstract) Circulation 1996;94(Suppl I):I-529.
50. + current by dofetilide. Circ Res 1993;72: 75-83.
51. Hoffman BF, Dangman KH: Are arrhythmias caused by automatic impulse generation? In Paes de Carvalho A, Hoffman BF, Lieberman M, eds: Normal and Abnormal Conduction in the Heart. Futura Publishing Co., Inc., Mount Kisco, NY, 1982, pp. 429-448.
52. Damiano BP, Rosen MR: Effects of pacing on triggered activity induced by early afterdepolarizations. Circulation 1984;69:1013-1025.
53. Ks, contributes to the longer action potential of the M cell. Circ Res 1995;76:351-365.
54. Wettwer E, Amos GJ, Posival H, et al: Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res 1994;75:473-482.
55. Montero M, Schmitt C: Differential effects of d-sotalol on endocardial and epicardial action potentials of human ventricular myocardium in dilated cardiomyopathy. J Cardiovasc Pharmacol 1994;24:883-889.
56. Hondeghem LM, Snyders DJ: Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 1990;81:686-690.
57. Stramba-Budiale M, Pessano P, Kirchengast M. et al: Effects of the potassium channel blocking agent ambasilide on ventricular arrhythmias induced by acute myocardial ischemia and sympathetic activation. Am Heart J 1995;129:549-556.
58. + channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. J Cardiovasc Pharmacol 1995;26:847-854.
59. Ks cardiac potassium current. Nature 1996;384:78-80.
60. Ks potassium channel. Nature 1996;384:80-83.